S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:AVCO

Avalon GloboCare News Headlines

$0.46
+0.02 (+4.05%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.42
$0.50
50-Day Range
$0.44
$0.78
52-Week Range
$0.40
$1.57
Volume
198,400 shs
Average Volume
138,423 shs
Market Capitalization
$41.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.83
Get Avalon GloboCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVCO and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Avalon GloboCare Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVCO
News Sentiment

0.47

0.27

Average
Business Services
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVCO Articles
This Week

4

1

AVCO Articles
Average Week



Avalon GloboCare (NASDAQ:AVCO) News Headlines Today

SourceHeadline
proactiveinvestors.com logoAvalon GloboCare to team up with Lu Daopei Hematology Institute to develop companion diagnostics for CAR-T cancer treatments
proactiveinvestors.com - May 18 at 5:06 PM
finance.yahoo.com logoAvalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular Therapy
finance.yahoo.com - May 18 at 9:20 AM
MarketBeat logoAvalon GloboCare Corp. (NASDAQ:AVCO) Sees Significant Decrease in Short Interest
americanbankingnews.com - May 18 at 2:42 AM
proactiveinvestors.com.au logoAvalon GloboCare files 16 patent applications related to cellular therapies as company moves towards clinical trials
proactiveinvestors.com.au - April 27 at 3:38 PM
seekingalpha.com logoAvalon GloboCare stock gains after expanding IP portfolio with 16 new patent applications
seekingalpha.com - April 27 at 10:38 AM
finance.yahoo.com logoAvalon GloboCare Expands IP Portfolio; Files 16 New Patent Applications
finance.yahoo.com - April 27 at 10:37 AM
benzinga.com logoAvalon Globocare Says Received Notice On Feb. 9 Co Received Notice From Nasdaq That Co Not In Compliance With Minimum Bid Price Requirement
benzinga.com - February 16 at 1:35 PM
finance.yahoo.com logoAvalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform
finance.yahoo.com - February 14 at 4:28 PM
proactiveinvestors.com logoAvalon GloboCare expands its cellular immuno-oncology program with addition of Chimeric Antigen Receptor-Natural Killer cell therapies
proactiveinvestors.com - February 14 at 11:26 AM
finance.yahoo.com logoAvalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
finance.yahoo.com - February 14 at 11:26 AM
finance.yahoo.com logoAvalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
finance.yahoo.com - January 4 at 1:21 PM
finance.yahoo.com logoAvalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market
finance.yahoo.com - December 22 at 12:48 PM
finance.yahoo.com logoAvalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market
finance.yahoo.com - December 22 at 12:48 PM
benzinga.com logoNASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)
benzinga.com - December 10 at 2:23 PM
proactiveinvestors.com logoAvalon GloboCare advances its AI-enhanced protein design technology for cellular therapy development in collaboration with MIT
proactiveinvestors.com - December 9 at 1:00 PM
finance.yahoo.com logoAvalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development
finance.yahoo.com - December 9 at 1:00 PM
nasdaq.com logoHere's Why Avalon GloboCare (NASDAQ:AVCO) Can Afford Some Debt
nasdaq.com - December 6 at 12:30 PM
finance.yahoo.com logoShareholders in Avalon GloboCare (NASDAQ:AVCO) are in the red if they invested three years ago
finance.yahoo.com - December 6 at 7:29 AM
finance.yahoo.com logoAvalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy
finance.yahoo.com - October 14 at 1:31 PM
proactiveinvestors.com logoAvalon GloboCare announces co-development of in-silico system to...
proactiveinvestors.com - October 8 at 9:38 AM
finance.yahoo.com logoAvalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases
finance.yahoo.com - October 7 at 1:52 PM
finance.yahoo.com logoAvalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
finance.yahoo.com - October 7 at 1:52 PM
finance.yahoo.com logoAvalon GloboCare Aims to Revolutionize Cell Therapy Market with a Faster, Safer CAR-T Treatment
finance.yahoo.com - September 30 at 6:06 PM
finance.yahoo.com logoAvalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30th
finance.yahoo.com - September 23 at 2:49 PM
finance.yahoo.com logoAVALON GLOBOCARE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO
finance.yahoo.com - September 8 at 5:56 PM
nasdaq.com logoAvalon GloboCare (NASDAQ:AVCO) shareholders have endured a 61% loss from investing in the stock three years ago
nasdaq.com - September 7 at 4:49 PM
benzinga.com logoAvalon GloboCare
benzinga.com - August 5 at 7:51 PM
finance.yahoo.com logoUPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare
finance.yahoo.com - August 4 at 1:27 PM
proactiveinvestors.com logoAvalon GloboCare, UPMC Hillman and University of Pittsburgh to develop new cancer immunotherapy
proactiveinvestors.com - August 2 at 1:14 PM
finance.yahoo.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRG, ALTA, AVCO, ICBK; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - July 20 at 2:00 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Avalon GloboCare Corp. Merger
finance.yahoo.com - July 19 at 12:15 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Avalon GloboCare Corp. - AVCO
finance.yahoo.com - July 17 at 1:29 AM
proactiveinvestors.com logoAvalon GloboCare says its planned acquisition target SenlangBio starts first-in-human clinical trial for recurrent brain cancer
proactiveinvestors.com - July 1 at 1:30 PM
proactiveinvestors.com logoAvalon GloboCare says SenlangBio will enhance its capabilities in cell and gene therapy
proactiveinvestors.com - June 30 at 10:08 AM
benzinga.com logoAvalon GloboCare Says Generated Revenues Of $1.2M For Three Months Ended Mar. 31, Sees FY21 Sales $5M-$7M
benzinga.com - June 28 at 2:09 PM
finance.yahoo.com logoAvalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio
finance.yahoo.com - June 28 at 9:09 AM
finance.yahoo.com logoLifshitz Law Firm, P.C. Announces Investigation of AVCO, ICON, KIN, and KNL
finance.yahoo.com - June 18 at 10:28 PM
finance.yahoo.com logoINVESTIGATION ALERT: Halper Sadeh LLP Investigates FBNC, AVCO, XEC, CLDR, SBBP; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - June 16 at 12:43 AM
businesswire.com logoAvalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Corp. Is Fair to Shareholders; Investors Are Encouraged to ...
businesswire.com - June 15 at 8:45 AM
finance.yahoo.com logoAvalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AVCO
finance.yahoo.com - June 14 at 7:14 PM
proactiveinvestors.com logoNA Proactive news snapshot: Avalon GloboCare, Planet 13 Holdings, Vicinity Motor, Ipsidy, Altiplano Metals UPDATE
proactiveinvestors.com - June 14 at 2:14 PM
proactiveinvestors.com logoAvalon GloboCare inks definitive agreement to acquire Chinese cell therapy company Senlang Biotechnology
proactiveinvestors.com - June 14 at 2:14 PM
benzinga.com logoAvalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights
benzinga.com - June 14 at 2:14 PM
finance.yahoo.com logoAvalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
finance.yahoo.com - June 14 at 9:13 AM
finance.yahoo.com logoAvalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021
finance.yahoo.com - June 11 at 1:57 PM
finance.yahoo.com logoIf You Had Bought Avalon GloboCare's (NASDAQ:AVCO) Shares Three Years Ago You Would Be Down 58%
finance.yahoo.com - June 9 at 11:41 AM
finance.yahoo.com logoAvalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit
finance.yahoo.com - June 8 at 12:39 PM
proactiveinvestors.com logoAvalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirus
proactiveinvestors.com - April 20 at 11:19 AM
nasdaq.com logoIs Avalon GloboCare (NASDAQ:AVCO) A Risky Investment?
nasdaq.com - April 8 at 12:52 PM
proactiveinvestors.com logoAvalon GloboCare to partner with University of Pittsburgh Medical Center Hillman Cancer Center to develop therapies using FLASH-CAR tech
proactiveinvestors.com - March 29 at 3:27 PM
Get Avalon GloboCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVCO and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.